Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy

Clinical trial NCT07088354 · RECRUITING

Trial details

NCT number: NCT07088354
Sponsor: Tongji Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Esophageal Squamous Cell Carcinoma Neoadjuvant Immunochemotherapy Pathological Complete Response Deep Learning

Start date: 2025-03-01
Primary completion: 2026-06-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.